1. Home
  2. WSBF vs DCTH Comparison

WSBF vs DCTH Comparison

Compare WSBF & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Waterstone Financial Inc. (MD)

WSBF

Waterstone Financial Inc. (MD)

HOLD

Current Price

$18.34

Market Cap

336.0M

Sector

Finance

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$9.71

Market Cap

311.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WSBF
DCTH
Founded
1921
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
336.0M
311.7M
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
WSBF
DCTH
Price
$18.34
$9.71
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$22.00
AVG Volume (30 Days)
65.5K
297.5K
Earning Date
04-21-2026
05-07-2026
Dividend Yield
3.29%
N/A
EPS Growth
46.53
107.53
EPS
1.48
0.07
Revenue
N/A
N/A
Revenue This Year
N/A
$24.54
Revenue Next Year
N/A
$33.15
P/E Ratio
$12.30
$137.57
Revenue Growth
N/A
N/A
52 Week Low
$11.61
$8.12
52 Week High
$18.88
$18.23

Technical Indicators

Market Signals
Indicator
WSBF
DCTH
Relative Strength Index (RSI) 59.57 56.79
Support Level $16.90 $8.90
Resistance Level $18.62 $10.17
Average True Range (ATR) 0.38 0.30
MACD 0.03 0.07
Stochastic Oscillator 74.87 77.50

Price Performance

Historical Comparison
WSBF
DCTH

About WSBF Waterstone Financial Inc. (MD)

Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The majority of its revenue comes from the Community Banking segment.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: